| Literature DB >> 25994353 |
Jenna L Mueller1, Henry L Fu1, Jeffrey K Mito2, Melodi J Whitley2, Rhea Chitalia1, Alaattin Erkanli3, Leslie Dodd4, Diana M Cardona5, Joseph Geradts5, Rebecca M Willett6, David G Kirsch2,7, Nimmi Ramanujam1.
Abstract
The goal of resection of soft tissue sarcomas located in the extremity is to preserve limb function while completely excising the tumor with a margin of normal tissue. With surgery alone, one-third of patients with soft tissue sarcoma of the extremity will have local recurrence due to microscopic residual disease in the tumor bed. Currently, a limited number of intraoperative pathology-based techniques are used to assess margin status; however, few have been widely adopted due to sampling error and time constraints. To aid in intraoperative diagnosis, we developed a quantitative optical microscopy toolbox, which includes acriflavine staining, fluorescence microscopy, and analytic techniques called sparse component analysis and circle transform to yield quantitative diagnosis of tumor margins. A series of variables were quantified from images of resected primary sarcomas and used to optimize a multivariate model. The sensitivity and specificity for differentiating positive from negative ex vivo resected tumor margins was 82 and 75%. The utility of this approach was tested by imaging the in vivo tumor cavities from 34 mice after resection of a sarcoma with local recurrence as a bench mark. When applied prospectively to images from the tumor cavity, the sensitivity and specificity for differentiating local recurrence was 78 and 82%. For comparison, if pathology was used to predict local recurrence in this data set, it would achieve a sensitivity of 29% and a specificity of 71%. These results indicate a robust approach for detecting microscopic residual disease, which is an effective predictor of local recurrence.Entities:
Keywords: image analysis; intraoperative imaging; logistic models; optical fluorescence imaging; soft tissue sarcoma
Mesh:
Year: 2015 PMID: 25994353 PMCID: PMC4575838 DOI: 10.1002/ijc.29611
Source DB: PubMed Journal: Int J Cancer ISSN: 0020-7136 Impact factor: 7.396